On 25 August, the State Drug Administration (SDA) issued a notification of drug approval for [Spironolactone Tablets], a new Class 3 filing of Zhejiang Shenzhou Pharmaceutical Co.
The Company has officially received the approval letter from the State Drug Administration on 6 September.
US creates painkiller from genetically modified yeast, cost expected to be 10 times lower
Yeast can be used not only to make flour and steam buns, but also to make painkillers. A study published in Science recently describes a method of producing a class of painkillers from genetically modified yeast. According to the researchers
Copyright©2022 Zhejiang Shenzhou Pharmaceutical Co., Ltd. All Rights Reserved